Literature DB >> 16300398

Identification of a specific inhibitor of the dishevelled PDZ domain.

Jufang Shan1, De-Li Shi, Junmei Wang, Jie Zheng.   

Abstract

The Wnt signaling pathways are involved in embryo development as well as in tumorigenesis. Dishevelled (Dvl) transduces Wnt signals from the receptor Frizzled (Fz) to downstream components in canonical and noncanonical Wnt signaling pathways. The Dvl PDZ domain is thought to play an essential role in both pathways, and we recently demonstrated that the Dvl PDZ domain binds directly to Fz receptors. In this study, using structure-based virtual ligand screening, we identified an organic molecule (NSC668036) from the National Cancer Institute small-molecule library that can bind to the Dvl PDZ domain. We then used molecular dynamics simulation to analyze the binding between the PDZ domain and NSC668036 in detail. In addition, we showed that, in Xenopus, as expected, NSC668036 inhibited the signaling induced by Wnt3A. This compound provides a basis for rational design of high-affinity inhibitors of the PDZ domain, which can block Wnt signaling by interrupting the Fz-Dvl interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300398     DOI: 10.1021/bi0512602

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  76 in total

Review 1.  Development of anticancer agents targeting the Wnt/β-catenin signaling.

Authors:  Xiangqian Zhang; Jijun Hao
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

Review 2.  Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.

Authors:  Shilong Zheng; Jiawang Liu; Yanyuan Wu; Tien L Huang; Guangdi Wang
Journal:  Future Med Chem       Date:  2015-12-16       Impact factor: 3.808

Review 3.  The Wnt signaling pathway in cancer.

Authors:  Yann Duchartre; Yong-Mi Kim; Michael Kahn
Journal:  Crit Rev Oncol Hematol       Date:  2015-12-24       Impact factor: 6.312

4.  Small-molecule synergist of the Wnt/beta-catenin signaling pathway.

Authors:  Qisheng Zhang; Michael B Major; Shinichi Takanashi; Nathan D Camp; Naoyuki Nishiya; Eric C Peters; Mark H Ginsberg; Xiaoying Jian; Paul A Randazzo; Peter G Schultz; Randall T Moon; Sheng Ding
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-25       Impact factor: 11.205

5.  Discovery of a small-molecule inhibitor of Dvl-CXXC5 interaction by computational approaches.

Authors:  Songling Ma; Jiwon Choi; Xuemei Jin; Hyun-Yi Kim; Ji-Hye Yun; Weontae Lee; Kang-Yell Choi; Kyoung Tai No
Journal:  J Comput Aided Mol Des       Date:  2018-04-07       Impact factor: 3.686

6.  Simulations of a specific inhibitor of the dishevelled PDZ domain.

Authors:  Xin Chen; Yuefan Deng
Journal:  J Mol Model       Date:  2008-10-25       Impact factor: 1.810

Review 7.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

8.  Identification of a small-molecule inhibitor of the PICK1 PDZ domain that inhibits hippocampal LTP and LTD.

Authors:  Thor S Thorsen; Kenneth L Madsen; Nelson Rebola; Mette Rathje; Victor Anggono; Anders Bach; Irina S Moreira; Nicolai Stuhr-Hansen; Tino Dyhring; Dan Peters; Thijs Beuming; Richard Huganir; Harel Weinstein; Christophe Mulle; Kristian Strømgaard; Lars Christian B Rønn; Ulrik Gether
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  The anti-helminthic niclosamide inhibits Wnt/Frizzled1 signaling.

Authors:  Minyong Chen; Jiangbo Wang; Jiuyi Lu; Michael C Bond; Xiu-Rong Ren; H Kim Lyerly; Larry S Barak; Wei Chen
Journal:  Biochemistry       Date:  2009-11-03       Impact factor: 3.162

Review 10.  Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.

Authors:  Laura Novellasdemunt; Pedro Antas; Vivian S W Li
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-19       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.